Please assess the completion status of the following clinical trial:

Trial Title: Forced-dose Titration of SPD489 in Adults With Binge Eating Disorder

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion~* Subject meets the following Diagnostic and Statistical Manual of Mental Disorders Fourth Edition - Text Revision (DSM-IV-TR) criteria for a diagnosis of binge eating disorder (BED).~* Binge eating disorder is of at least moderate severity in which subjects report at least 3 binge eating days per week.~* Subject has a body mass index (BMI) of \>24 and \<46.~Exclusion~* Subject has concurrent symptoms of bulimia nervosa or anorexia nervosa.~* Subject is considered a suicide risk or risk to harm others.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 55 Years
- Healthy Volunteers: f

Study Arms:
- SPD489 30 mg (Type: EXPERIMENTAL): None
- SPD489 50 mg (Type: EXPERIMENTAL): None
- SPD489 70 mg (Type: EXPERIMENTAL): None
- Placebo (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).